Techniques in Coloproctology

, Volume 17, Issue 1, pp 89–94 | Cite as

Sexual function and quality of life after surgical treatment for anal fistulas in Crohn’s disease

  • S. RissEmail author
  • K. Schwameis
  • M. Mittlböck
  • M. Pones
  • H. Vogelsang
  • W. Reinisch
  • M. Riedl
  • A. Stift
Original Article



The aim of this study was to assess sexual function and quality of life (QoL) in patients after surgery for perianal Crohn’s disease.


Eighty-eight consecutive patients with perianal Crohn’s disease, operated on at the Medical University of Vienna, completed a self-administered questionnaire including the International Index of Erectile Function (IIEF), Female Sexual Function Index (FSFI), Short Form-12 Health Survey (SF-12), and the Inflammatory Bowel Disease Questionnaire (IBDQ). Patients with a current stoma were excluded from further analysis. The median follow-up time was 104 months (range 3–186 months). Healthy subjects served as controls for each case and were matched by age (±6 years) and gender. Forty-seven (68 %) female and 22 male patients with a median age of 46.5 years (range 18–64 years) were analyzed. Eleven (16 %) patients had simple and 58 (84 %) complex anal fistulas.


The median SF-12 physical health score of the patients was significantly lower (47.9 (range 25.5–57.2)) than that of the controls (54.3 (range 34.6–61.8); p = 0.03). Not surprisingly, the median total sore of the IBDQ of the controls was significantly better than that of the patients (controls: 188.5 (range 125–206.5), patients: 157 (range 60–199.5); p < 0.0001). Analysis with the multiple logistic regression test showed that type of operation, >1 perianal fistula opening, and active Crohn’s disease were independent risk factors for a worse IBDQ (p = 0.03, p = 0.015 and p < 0.0001). Interestingly, the median FSFI and IIEF score were not found to be significant different in any domain.


QoL but not sexual function is significantly influenced by surgery for perianal Crohn’s disease.


Perianal Crohn’s disease Quality of life Sexual function 


Conflict of interest



  1. 1.
    Schwartz DA, Loftus EV Jr, Tremaine WJ et al (2002) The natural history of fistulizing Crohn’s disease in Olmsted County, Minnesota. Gastroenterology 122:875–880PubMedCrossRefGoogle Scholar
  2. 2.
    Singh B, McC Mortensen NJ, Jewell DP, George B (2004) Perianal Crohn’s disease. Br J Surg 91:801–814PubMedCrossRefGoogle Scholar
  3. 3.
    Taxonera C, Schwartz DA, Garcia-Olmo D (2009) Emerging treatments for complex perianal fistula in Crohn’s disease. World J Gastroenterol 15:4263–4272PubMedCrossRefGoogle Scholar
  4. 4.
    Makowiec F, Jehle EC, Starlinger M (1995) Clinical course of perianal fistulas in Crohn’s disease. Gut 37:696–701PubMedCrossRefGoogle Scholar
  5. 5.
    Kasparek MS, Glatzle J, Temeltcheva T, Mueller MH, Koenigsrainer A, Kreis ME (2007) Long-term quality of life in patients with Crohn’s disease and perianal fistulas: influence of fecal diversion. Dis Colon Rectum 50:2067–2074PubMedCrossRefGoogle Scholar
  6. 6.
    Parks AG, Gordon PH, Hardcastle JD (1976) A classification of fistula-in-ano. Br J Surg 63:1–12PubMedCrossRefGoogle Scholar
  7. 7.
    Dubsky PC, Stift A, Friedl J, Teleky B, Herbst F (2008) Endorectal advancement flaps in the treatment of high anal fistula of cryptoglandular origin: full-thickness vs. mucosal-rectum flaps. Dis Colon Rectum 51:852–857PubMedCrossRefGoogle Scholar
  8. 8.
    Janke KH, Klump B, Steder-Neukamm U, Hoffmann J, Hauser W (2006) Validation of the German version of the inflammatory bowel disease questionnaire (competence network IBD, IBDQ-D). Psychother Psychosom Med Psychol 56:291–298PubMedCrossRefGoogle Scholar
  9. 9.
    Ware J Jr, Kosinski M, Keller SD (1996) A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233PubMedCrossRefGoogle Scholar
  10. 10.
    Rosen R, Brown C, Heiman J et al (2000) The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26:191–208PubMedCrossRefGoogle Scholar
  11. 11.
    Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49:822–830PubMedCrossRefGoogle Scholar
  12. 12.
    Wiegel M, Meston C, Rosen R (2005) The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 31:1–20PubMedCrossRefGoogle Scholar
  13. 13.
    Timmer A, Kemptner D, Bauer A, Takses A, Ott C, Furst A (2008) Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis. BMC Gastroenterol 8:45PubMedCrossRefGoogle Scholar
  14. 14.
    El-Gazzaz G, Hull T, Mignanelli E, Hammel J, Gurland B, Zutshi M (2010) Analysis of function and predictors of failure in women undergoing repair of Crohn’s related rectovaginal fistula. J Gastrointest Surg 14:824–829PubMedCrossRefGoogle Scholar
  15. 15.
    Takesue Y, Ohge H, Yokoyama T, Murakami Y, Imamura Y, Sueda T (2002) Long-term results of seton drainage on complex anal fistulae in patients with Crohn’s disease. J Gastroenterol 37:912–915PubMedCrossRefGoogle Scholar
  16. 16.
    Delaney CP, Kiran RP, Senagore AJ et al (2003) Quality of life improves within 30 days of surgery for Crohn’s disease. J Am Coll Surg 196:714–721PubMedCrossRefGoogle Scholar
  17. 17.
    Tillinger W, Mittermaier C, Lochs H, Moser G (1999) Health-related quality of life in patients with Crohn’s disease: influence of surgical operation—a prospective trial. Dig Dis Sci 44:932–938PubMedCrossRefGoogle Scholar
  18. 18.
    Cadahia V, Garcia-Carbonero A, Vivas S et al (2004) Infliximab improves quality of life in the short-term in patients with fistulizing Crohn’s disease in clinical practice. Rev Esp Enferm Dig 96:369–374PubMedCrossRefGoogle Scholar
  19. 19.
    Ng SC, Plamondon S, Gupta A, Burling D, Kamm MA (2009) Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn’s fistulas. Aliment Pharmacol Ther 30:757–766PubMedCrossRefGoogle Scholar
  20. 20.
    Sands BE, Anderson FH, Bernstein CN et al (2004) Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med 350:876–885PubMedCrossRefGoogle Scholar
  21. 21.
    Blondel-Kucharski F, Chircop C, Marquis P et al (2001) Health-related quality of life in Crohn’s disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol 96:2915–2920PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • S. Riss
    • 1
    Email author
  • K. Schwameis
    • 1
  • M. Mittlböck
    • 2
  • M. Pones
    • 1
  • H. Vogelsang
    • 3
  • W. Reinisch
    • 3
  • M. Riedl
    • 1
  • A. Stift
    • 1
  1. 1.Department of General SurgeryMedical University of ViennaViennaAustria
  2. 2.Center for Medical Statistics, Informatics and Intelligent SystemsViennaAustria
  3. 3.Division of Gastroenterology and Hepatology, Department of Internal Medicine IIIViennaAustria

Personalised recommendations